Definium Therapeutics (DFTX) Interest Coverage Ratio (2021 - 2026)
Definium Therapeutics' (DFTX) quarterly Interest Coverage Ratio came in at 0.0 in Q1 2026, up 100.0% year-on-year from 0.0 in Q1 2025, and up 100.0% on a QoQ basis from 37.0 in Q4 2025.
Definium Therapeutics (DFTX) Interest Coverage Ratio (2021 - 2026) Analysis & Trends
Definium Therapeutics (DFTX) has 6 years of Interest Coverage Ratio data on file, last reported at 0.0 in Q1 2026.
- On a quarterly basis, Interest Coverage Ratio rose 100.0% year-over-year to 0.0 in Q1 2026; TTM through Mar 2026 was 0.0, a 99.99% increase from a year earlier, with the FY2025 full-year figure at 0.01, up 78.52% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 0.0, up from 37.0 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for DFTX reached as high as 453.16 in Q4 2023 and fell as low as 379.01 in Q2 2023.
- Historically, Interest Coverage Ratio has averaged 35.91 across 5 years, with a median of 35.13 in 2025.
- On a YoY basis, Interest Coverage Ratio climbed as much as 117814.86% in 2023 and fell as far as 13973.04% in 2023.
- Year by year, Interest Coverage Ratio stood at 0.38 in 2022, then jumped by 117814.86% to 453.16 in 2023, then tumbled by 110.92% to 49.48 in 2024, then rose by 25.24% to 37.0 in 2025, then soared by 100.0% to 0.0 in 2026.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 0.0 in Q1 2026, 37.0 in Q4 2025, and 35.13 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Definium Therapeutics | 4.47 Bn | 4.47 Bn | - | 0.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | -37.00 |
| Sep 30, 2025 | -35.13 |
| Jun 30, 2025 | -0.02 |
| Mar 31, 2025 | -53.42 |
| Dec 31, 2024 | -49.48 |
| Sep 30, 2024 | -34.10 |
| Jun 30, 2024 | -52.48 |
| Mar 31, 2024 | -51.16 |
| Dec 31, 2023 | 453.16 |
| Sep 30, 2023 | -23.19 |
| Jun 30, 2023 | -379.01 |
| Mar 31, 2023 | -274.50 |
| Dec 31, 2022 | -0.38 |
| Mar 31, 2022 | -1.95 |
| Dec 31, 2021 | -30.59 |